1. |
Bongso A, Fong CY.The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.Stem Cell Rev, 2013, 9(2):226-240.
|
2. |
Zebardast N, Lickorish D, Davies JE.Human umbilical cord perivascular cells (HUCPVC):A mesenchymal cell source for dermal wound healing.Organogenesis, 2010, 6(4):197-203.
|
3. |
Hong SH, Maghen L, Kenigsbcerg S, et al.Ontogeny of human umbilical cord perivascular cells:molecular and fate potential changes during gestation.Stem Cells Dev, 2013, 22(17):2425-2439.
|
4. |
Librach CL, Yie SM, Xiao R.Smmethod of isolation and use of cells derived from first trimester umbilical cord tissue.US, 20090074731[P].2009-03-19.
|
5. |
Lumelsky N, Blondel O, Laeng P, et al.Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.Science, 2001, 292(5520):1389-1394.
|
6. |
Jiang W, Shi Y, Zhao D, et al.In vitro derivation of functional insulin-producing cells from human embryonic stem cells.Cell Res, 2007, 17(4):333-344.
|
7. |
Lee SH, Song KS, Kim JY, et al.Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.Bioorg Med Chem, 2011, 19(19):5813-5832.
|
8. |
Otake K, Azukizawa S, Takahashi K, et al.2-Acyl-tetrahydroisoquinoline-3-carboxylic acids:lead compounds with triple actions, peroxisome proliferator-activated receptor α/γ agonist and protein-tyrosine phosphatase 1B inhibitory activities.Chem Pharm Bull (Tokyo), 2011, 59(7):876-879.
|
9. |
Shapiro AM, Lakey JR, Ryan EA, et al.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med, 2000, 343(4):230-238.
|
10. |
Matsumoto S, Tanaka K.Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs).J Hepatobiliary Pancreat Surg, 2005, 12(3):227-230.
|
11. |
Suva D, Garavaglia G, Menetrey J, et al.Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells.J Cell Physiol, 2004, 198(1):110-118.
|
12. |
Yu M, Xiao Z, Shen L, et al.Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not.Br J Haematol, 2004, 124(5):666-675.
|
13. |
Tsai MS, Lee JL, Chang YJ, et al.Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.Hum Reprod, 2004, 19(6):1450-1456.
|
14. |
Guillot PV, Gotherstrom C, Chan J, et al.Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.Stem Cells, 2007, 25(3):646-654.
|
15. |
Sarugaser R, Lickorish D, Baksh D, et al.Human umbilical cord perivascular (HUCPV) cells:a source of mesenchymal progenitors.Stem Cells, 2005, 23(2):220-229.
|
16. |
Can A, Karahuseyinoglu S.Concise review:human umbilical cord stroma with regard to the source of fetus-derived stem cells.Stem Cells, 2007, 25(11):2886-2895.
|